We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+1.13%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$10.4B
AUM Growth
-$279M
(-2.6%)
Cap. Flow
-$218M
Cap. Flow
% of AUM
-2.1%
Top 10 Holdings %
Top 10 Hldgs %
17.29%
Holding
1,364
New
413
Increased
268
Reduced
302
Closed
358
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$105M |
| 2 |
EMC
EMC CORPORATION
EMC
|
+$103M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$97.6M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$77.4M |
| 5 |
Humana
HUM
|
+$71.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$125M |
| 2 |
Perrigo
PRGO
|
+$103M |
| 3 |
AGN
Allergan plc
AGN
|
+$99.6M |
| 4 |
Pfizer
PFE
|
+$90M |
| 5 |
Viatris
VTRS
|
+$88.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 15.63% |
| 2 | Healthcare | 15.57% |
| 3 | Communication Services | 13.26% |
| 4 | Technology | 11.56% |
| 5 | Financials | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Burlington
BURL
$22B
| $1.16M | 0.01% |
20,569
-207,985
| -91% | -$10.9M |
|
|
HEES
677
DELISTED
H&E Equipment Services
HEES
| $1.14M | 0.01% |
65,178
-432
| -0.7% | -$6.26K |
|
678
Mueller Water Products
MWA
$3.92B
| $1.14M | 0.01% |
115,119
+96,327
| +513% | +$824K |
|
679
East-West Bancorp
EWBC
$17.9B
| $1.14M | 0.01% |
+34,960
| New | +$1.14M |
|
680
Live Nation Entertainment
LYV
$41.2B
| $1.12M | 0.01% |
+50,296
| New | +$1.1M |
|
681
SPS Commerce
SPSC
$2.25B
| $1.12M | 0.01% |
+52,240
| New | +$1.31M |
|
|
RSPP
682
DELISTED
RSP Permian, Inc.
RSPP
| $1.12M | 0.01% |
38,457
+2,007
| +6% | +$47.1K |
|
|
HAR
683
DELISTED
Harman International Industries
HAR
| $1.12M | 0.01% |
12,541
-279,678
| -96% | -$22.2M |
|
|
SN
684
DELISTED
Sanchez Energy Corporation
SN
| $1.11M | 0.01% |
201,434
+123,364
| +158% | +$478K |
|
|
NTLS
685
DELISTED
NTELOS HLDGS CORP COM
NTLS
| $1.1M | 0.01% |
120,000
| – | – |
|
686
New York Times
NYT
$11.6B
| $1.1M | 0.01% |
+88,538
| New | +$1.12M |
|
|
EGN
687
DELISTED
Energen
EGN
| $1.1M | 0.01% |
+30,045
| New | +$931K |
|
|
IQNT
688
DELISTED
Inteliquent, Inc.
IQNT
| $1.09M | 0.01% |
68,219
+56,978
| +507% | +$942K |
|
|
GHDX
689
DELISTED
Genomic Health, Inc.
GHDX
| $1.08M | 0.01% |
43,599
-129,620
| -75% | -$3.56M |
|
690
Covenant Logistics
CVLG
$1.18B
| $1.07M | 0.01% |
+88,570
| New | +$893K |
|
691
Marriott Vacations Worldwide
VAC
$3.24B
| $1.06M | 0.01% |
15,666
-47,840
| -75% | -$2.71M |
|
692
Universal Insurance Holdings
UVE
$1.16B
| $1.05M | 0.01% |
59,133
+47,602
| +413% | +$883K |
|
|
XIFR
693
XPLR Infrastructure LP
XIFR
$1.18B
| $1.05M | 0.01% |
38,734
-15,923
| -29% | -$425K |
|
694
Molina Healthcare
MOH
$10.3B
| $1.05M | 0.01% |
+16,280
| New | +$967K |
|
695
Acadia Pharmaceuticals
ACAD
$4.25B
| $1.04M | 0.01% |
+37,174
| New | +$811K |
|
696
TherapeuticsMD
TXMD
$23.8M
| $1.03M | 0.01% |
+3,230
| New | +$1.1M |
|
|
AHL
697
DELISTED
ASPEN Insurance Holding Limited
AHL
| $1.03M | 0.01% |
21,620
-23,994
| -53% | -$1.09M |
|
|
EOCC
698
DELISTED
Enel Generacion Chile S.A.
EOCC
| $1.03M | 0.01% |
+35,712
| New | +$965K |
|
|
LMNX
699
DELISTED
Luminex Corp
LMNX
| $1.03M | 0.01% |
52,913
+29,551
| +126% | +$563K |
|
700
Inogen
INGN
$167M
| $1.03M | 0.01% |
+22,818
| New | +$813K |
|
Similar funds
Marshall Wace's Q1 2016 Portfolio in Review
As of Q1 2016, Marshall Wace held 1,364 positions worth $10.4B, down 2.6% from $10.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Marshall Wace's Q1 2016 filing shows 413 new, 268 increased, 302 reduced and 358 closed positions. Its largest new stake was iShares MSCI Emerging Markets ETF: 3,149,620 shares worth $108M. The largest sale was Bristol-Myers Squibb, an estimated $125M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 12% a quarter earlier, followed by Healthcare and Communication Services.
- Marshall Wace's largest Q1 2016 buy was iShares MSCI Emerging Markets ETF: 3,149,620 shares worth $108M.
- Marshall Wace added most to Adobe in Q1 2016, an estimated $105M increase.
- Marshall Wace's biggest Q1 2016 reduction was Bristol-Myers Squibb, cutting an estimated $125M.
- Marshall Wace fully exited Perrigo in Q1 2016, selling an estimated $103M.
- Marshall Wace's ten largest holdings make up 17% of its $10.4B portfolio in Q1 2016.
- Marshall Wace opened 413 new positions and closed 358 in Q1 2016.
- Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $10.4B.
Based on Marshall Wace's 13F filing for Q1 2016, filed 13 May 2016.